Half of advanced cancer patients given new drug saw their tumours stop growing or disappear completely as first clinical trial provides ‘encouraging’ results
Researchers in the UK tested berzosertib on 40 patients with advanced tumoursDespite being an early trial to evaluate safe dosage, results were 'encouraging'Berzosertib works by blocking the protein in cancer cells that…